image
Roivant Sciences Ltd. ROIV
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 11.2
-0.0892 %
$ 7.61 B
Market Cap
-14.93
P/E
Price Target Average
38.39%
Revenue Forecast Estimate
84.63%
EBIT Estimate
--4.77%
Net Income Estimate
--0.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Roivant Sciences Ltd.
image
Wall Street analysts predict an average 1-year price target for ROIV of $15.5 , with forecasts ranging from a low of $12.5 to a high of $17 .
ROIV Lowest Price Target Wall Street Target
12.5 USD 11.61%
ROIV Average Price Target Wall Street Target
15.5 USD 38.39%
ROIV Highest Price Target Wall Street Target
17 USD 51.79%
Price
Max Price Target
Min Price Target
Average Price Target
1717161615151414131312121111101099Jun '24Jun '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Aug '25Aug '25Oct '25Oct '25Dec '25Dec '25Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ROIV

image
$2.0b$2.0b$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.02023202320242024202520252026202620272027202820282029202920292029
EBIT FORECAST

EBIT Forecast Chart ROIV

image
$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)2023202320242024202520252026202620272027202820282029202920292029
NET INCOME FORECAST

Net Income Chart ROIV

image
$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)2023202320242024202520252026202620272027202820282029202920292029